You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
|
|---|---|
| Published in |
BMC Cancer, April 2011
|
| DOI | 10.1186/1471-2407-11-144 |
| Pubmed ID | |
| Authors |
Seung Joon Lee, Candice Krauthauser, Victoria Maduskuie, Paul T Fawcett, James M Olson, Sigrid A Rajasekaran |
| Abstract |
Medulloblastoma is the most common brain tumor in children, and its prognosis is worse than for many other common pediatric cancers. Survivors undergoing treatment suffer from serious therapy-related side effects. Thus, it is imperative to identify safer, effective treatments for medulloblastoma. In this study we evaluated the anti-cancer potential of curcumin in medulloblastoma by testing its ability to induce apoptosis and inhibit tumor growth in vitro and in vivo using established medulloblastoma models. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 17% |
| United Kingdom | 1 | 17% |
| Spain | 1 | 17% |
| United States | 1 | 17% |
| Unknown | 2 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 83% |
| Scientists | 1 | 17% |
Mendeley readers
The data shown below were compiled from readership statistics for 104 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 2% |
| United States | 2 | 2% |
| Germany | 1 | <1% |
| Unknown | 99 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 17 | 16% |
| Student > Ph. D. Student | 14 | 13% |
| Student > Master | 14 | 13% |
| Researcher | 12 | 12% |
| Student > Postgraduate | 7 | 7% |
| Other | 18 | 17% |
| Unknown | 22 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 24 | 23% |
| Medicine and Dentistry | 18 | 17% |
| Biochemistry, Genetics and Molecular Biology | 15 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 7% |
| Chemistry | 6 | 6% |
| Other | 8 | 8% |
| Unknown | 26 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2014.
All research outputs
#6,665,721
of 22,656,971 outputs
Outputs from BMC Cancer
#1,711
of 8,238 outputs
Outputs of similar age
#36,627
of 109,262 outputs
Outputs of similar age from BMC Cancer
#14
of 36 outputs
Altmetric has tracked 22,656,971 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 8,238 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,262 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.